Gastroesophageal Reflux Disease (GERD) Market Report 2026

Gastroesophageal Reflux Disease (GERD) Market Overview

• Gastroesophageal Reflux Disease (GERD) market size has reached to $5.33 billion in 2025 • Expected to grow to $6.2 billion in 2030 at a compound annual growth rate (CAGR) of 3.3% • Growth Driver: Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal Reflux Disease (GERD) Market • Market Trend: Innovative Gerd Treatment Technologies Shape The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastroesophageal Reflux Disease (GERD) Market?

Gastroesophageal reflux disease (GERD) is a condition in which stomach acid flows back into the esophagus, causing irritation and discomfort. The treatment for the disease includes various medical strategies and interventions employed to manage the symptoms and complications associated with gastroesophageal reflux disease. The main drug types of gastroesophageal reflux disease are antacids, proton pump inhibitors, h2 receptor blockers, pro kinetic agents, dopamine receptor antagonists, endocinch, stretta, asphyx, transoral incisionless fundoplication (TIF). Antacids are drugs that neutralize stomach acid by raising the pH level in the stomach. The various procedures include invasive and minimally invasive. These are used by various end-users such as hospitals, homecare and specialty clinics.

What Is The Gastroesophageal Reflux Disease (GERD) Market Growth Forecast?

The gastroesophageal reflux disease (gerd) market size is expected to see steady growth in the next few years. It will grow to $6.2 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to growth in minimally invasive reflux procedures, demand for long-term symptom management, innovation in endoscopic devices, rising geriatric population, increased patient awareness. Major trends in the forecast period include rising long-term use of proton pump inhibitors, increased adoption of minimally invasive gerd procedures, growing awareness of lifestyle-based disease management, expansion of endoscopic treatment options, higher diagnosis rates through improved screening.

Global Gastroesophageal Reflux Disease (GERD) Market Segmentation

1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist 2) By Procedure: Invasive, Minimally Invasive 3) By End-Users: Hospital, Homecare, Specialty Clinics Subsegments: 1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide 2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole 3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine 4) By Prokinetic Agents: Metoclopramide, Domperidone 5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol

What Is The Driver Of The Gastroesophageal Reflux Disease (GERD) Market?

The growing prevalence of esophageal diseases is expected to propel the growth of the gastroesophageal reflux disease (GERD) market going forward. Esophageal diseases are medical conditions that affect the esophagus, a muscular tube connecting the mouth to the stomach. The treatment of esophageal diseases aims to alleviate symptoms, improve quality of life and prevent complications, ultimately promoting better overall health and well-being for gastroesophageal reflux disease-affected individuals. For instance, in January 2023, according to the American Cancer Society, a US-based Professional organization, about 21,560 new esophageal cancer cases are diagnosed yearly in the United States, with 16,120 deaths from esophageal cancer. Therefore, the growing prevalence of esophageal diseases drives the growth of the gastroesophageal reflux disease (GERD) industry.

Key Players In The Global Gastroesophageal Reflux Disease (GERD) Market

Major companies operating in the gastroesophageal reflux disease (gerd) market are GlaxoSmithKline PLC, SRS Life Sciences, Takeda Pharmaceutical Company Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc.

Global Gastroesophageal Reflux Disease (GERD) Market Trends and Insights

Major companies operating in the gastroesophageal reflux disease (GERD) market are focusing on introducing innovative gastroesophageal reflux disease treatment devices to sustain their position in the market. For instance, in April 2023, Laborie Medical Technologies, a US-based medical technology company, launched the new alpHaONE wireless pH-capsule reflux testing diagnostic system designed for diagnosing gastroesophageal reflux disease (GERD). The system provides up to 96 hours of monitoring data and offers a compact design with enlarged buttons and a fail-safe capsule delivery system. The system features a software application with a virtual instruction program and user-customizable symptom buttons for improved user experience.

What Are Latest Mergers And Acquisitions In The Gastroesophageal Reflux Disease (GERD) Market?

In July 2024, Merit Medical Systems, Inc., a US-based provider of healthcare technology and medical devices for radiology, cardiology, oncology, and endoscopy, acquired EndoGastric Solutions, Inc. for an undisclosed amount. With this acquisition, Merit expanded its minimally invasive endoscopy portfolio and strengthened its presence in the gastroesophageal reflux disease (GERD) treatment market. EndoGastric Solutions, Inc., a US-based medical device company, developed and commercialized the EsophyX Z+ system, a transoral incisionless fundoplication device designed for the treatment of chronic GERD.

Regional Outlook

North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastroesophageal Reflux Disease (GERD) Market?

The gastroesophageal reflux disease (GERD) market consists of revenues earned by entities by providing pharmaceutical therapies, surgical procedures and diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroesophageal reflux disease (GERD) market also includes sales of gamma-aminobutyric acid type B receptor agonists and alginate antacids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastroesophageal Reflux Disease (GERD) Market Report 2026?

The gastroesophageal reflux disease (gerd) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastroesophageal reflux disease (gerd) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.